Vivani Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Revenue	0	0	0	0	3.38	Upgrade
Revenue Growth (YoY)	-	-	-	-	-51.00%	Upgrade
Cost of Revenue	0	0	0	-0.5	2.15	Upgrade
Gross Profit	0	0	0	0.5	1.23	Upgrade
Selling, General & Admin	10	7.07	2.32	6.64	15.33	Upgrade
Research & Development	16.97	14.17	11	4.84	13.14	Upgrade
Other Operating Expenses	0	0	0	3.92	6.71	Upgrade
Operating Expenses	26.97	21.24	13.32	15.4	35.18	Upgrade
Operating Income	-26.97	-21.24	-13.32	-14.9	-33.95	Upgrade
Other Expense / Income	-1.31	-7.35	-0.55	-0.02	-0.36	Upgrade
Pretax Income	-25.65	-13.89	-12.77	-14.88	-33.59	Upgrade
Net Income	-25.65	-13.89	-12.77	-14.88	-33.59	Upgrade
Shares Outstanding (Basic)	51	38	33	7	5	Upgrade
Shares Outstanding (Diluted)	51	38	33	7	5	Upgrade
Shares Change	32.98%	15.56%	382.51%	39.89%	77.27%	Upgrade
EPS (Basic)	-0.50	-0.36	-0.39	-2.16	-6.84	Upgrade
EPS (Diluted)	-0.50	-0.36	-0.39	-2.16	-6.84	Upgrade
Free Cash Flow	-24.59	-19.13	-11.52	-17.15	-28.12	Upgrade
Free Cash Flow Per Share	-0.48	-0.50	-0.35	-2.50	-5.74	Upgrade
Gross Margin	-	-	-	-	36.31%	Upgrade
Operating Margin	-	-	-	-	-1004.85%	Upgrade
Profit Margin	-	-	-	-	-994.14%	Upgrade
Free Cash Flow Margin	-	-	-	-	-832.26%	Upgrade
EBITDA	-24.39	-13.54	-12.41	-14.71	-33.18	Upgrade
EBITDA Margin	-	-	-	-	-981.89%	Upgrade
Depreciation & Amortization	1.26	0.35	0.36	0.17	0.41	Upgrade
EBIT	-25.65	-13.89	-12.77	-14.88	-33.59	Upgrade
EBIT Margin	-	-	-	-	-994.14%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).